Lesley Stolz, PhD, fosters Johnson & Johnson’s external R&D engine and supports the innovation community by leading the Johnson & Johnson Innovation, JLABS business on the West Coast. She has 20 years of business and corporate development experience working for companies that have been both technology platform and therapeutics focused. Previously, she was Senior Director of Transactions negotiating partnering deals for Johnson & Johnson Innovation at the California Innovation Center. Prior to joining Johnson & Johnson Innovation, she held executive positions with BioTime, Inc., Sutro Biopharma, Inc., and Sunesis Pharmaceuticals where she was responsible for corporate strategy, fundraising and all aspects of partnering. Earlier in her career, she served as Senior Director, Business Development for Aerovance, Inc. and for GPC Biotech AG in Munich, Germany from 2002 to 2006. She also served in senior management positions at Cell Genesys, Discovery Partners International and Axys Pharmaceuticals. Dr. Stolz received her Ph.D. in chemistry, and conducted postdoctoral research at Harvard Medical School’s Department of Biochemistry and Molecular Pharmacology.